Welcome from the Chief
Welcome to the Division of Allergy, Immunology and Rheumatology (AIR). This Division has a long history of providing excellence in patient care, medical research, and education that dates back to the 1950’s. Our current faculty and staff are not only committed to carrying on this tradition but are also recognized nationally as leaders in their field.
We provide timely, comprehensive, individualized, state-of-the-art medical care to patients with musculoskeletal, autoimmune, and allergic diseases. We act as advocates for our patients and seek to improve treatments outcomes and quality of life.
Our faculty perform cutting edge investigation in basic science and translational research as we seek to expand our understanding of the mechanisms that underlie inflammatory, allergic and autoimmune disorders, with the goal of developing more effective and less toxic treatments.
We are also committed to educating the next generation of Allergists/Immunologists and Rheumatologists. Being a combined division with close ties to Pediatrics as well as many other Departments in the Medical Center including Orthopedics, Dermatology and others offers our fellows numerous unique opportunities.
Jennifer Anolik, M.D., Ph.D.
Division Chief
Associate Chair of Research, Department of Medicine
Make an Appointment
Allergy & Immunology: (585) 486-0930
Rheumatology: (585) 486-0901
We now offer self-scheduling for follow-up appointments through MyChart, our online patient portal!
Upcoming Speakers and Events
Allergy Grand Rounds
Paul J. Maglione, MD, PhD
Assistant Professor of Medicine
Mount Sinai Center for Eosinophilic Disorders
Boston University Chobanian & Avedisian School of Medicine: Pulmonary Center
April 17, 2025
AIR/Dermatology Grand Rounds
Ethan A. Lerner, MD, Ph
Associate Professor of Dermatology
Harvard Medical School
May 29, 2025
Save the Date: World Allergy Week 2025
June 29, 2025
Division of Allergy, Immunology & Rheumatology researchers join NIH's Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) Program, a 5-year $58.5 million initiative to target new therapies for rheumatoid arthritis and psoriatic disease. Dr. Anolik will serve as principal lead for the RA team, while Dr. Ritchilin will lead the psoriasis/psoriatic arthritis team.
The University of Rochester is a World Allergy Center of Excellence, whose purpose is to intensify and accelerate multi-disciplinary scientific and clinical innovation, education, and advocacy worldwide, providing excellence in education, research, and training in Allergy, Asthma and Clinical Immunology.
Jennifer Anolik,
MD, PhD
Jennifer Anolik Named Chief of Allergy, Immunology & Rheumatology
A pioneer of autoimmune diseases research, Anolik was named chief of the Allergy, Immunology and Rheumatology Division. She is hitting the ground running, with the introduction of an R38-funded program to expand residents’ research opportunities.
Recent News
February 24, 2025
Theresa Bingemann elected to Program Directors Assembly Executive Committee for AAAAI
January 6, 2025
Jennifer Anolik Named Chief of Allergy, Immunology and Rheumatology Division
December 3, 2024
AIR Will Begin Seeing Patients in Geneseo